Jinvik Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in East Delhi, Delhi, India, established in 2024.
2024 East Delhi, Delhi, India Active
Last Updated:
Access Report
About Jinvik Pharmaceuticals Private Limited

Jinvik Pharmaceuticals Private Limited, a active private limited company, was established on 27 June 2024 in East Delhi, Delhi, India. it holds CIN: U47721DL2024PTC433477. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Himanshu Dubey (Director), Vivek Sharma (Director), Lokesh Vats (Director). Past directors included Himanshu Dubey, Vivek Sharma. It is based at D-565, Gali No-14, Kh No-517, Bhajanpura, East Delhi, Delhi, 110053.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U47721DL2024PTC433477

  • Registration Number

    433477

  • Incorporation Date

    27 June 2024

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 7 Months
Company report

Jinvik Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Jinvik Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Jinvik Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Himanshu Dubey Director 27 Jun 2024 Current
Vivek Sharma Director 27 Jun 2024 Current
Lokesh Vats Director 27 Jun 2024 Current
Preety Sharma Director 12 Jun 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 13 Jun 2025 Past
Pramod Abcsdd Director 13 Jun 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Jinvik Pharmaceuticals.

Enhance accessibility to Jinvik Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Jinvik Pharmaceuticals revenue growth over time
Jinvik Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Jinvik Pharmaceuticals?

Unlock access to Jinvik Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Jinvik Pharmaceuticals?

Unlock and access historical data on people associated with Jinvik Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Jinvik Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jinvik Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Jinvik Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Preety Sharma was appointed as a Director was appointed as a Director on 12 Jun 2025 & has been associated with this company since 8 months 12 days . was recorded as a recent event.

  • Director Appointment

    Himanshu Dubey was appointed as a Director was appointed as a Director on 27 Jun 2024 & has been associated with this company since 1 year 7 months . was recorded as a recent event.

  • Director Appointment

    The activity Vivek Sharma was appointed as a Director was appointed as a Director on 27 Jun 2024 & has been associated with this company since 1 year 7 months . was completed.

  • Director Appointment

    Progress on Lokesh Vats was appointed as a Director was appointed as a Director on 27 Jun 2024 & has been associated with this company since 1 year 7 months . was documented.

  • Company Incorporation

    Progress on Jinvik Pharmaceuticals Private Limited was registered on 27 Jun 2024 with Roc Delhi & aged 1 year 7 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Jinvik Pharmaceuticals Private Limited?

The CIN of Jinvik Pharmaceuticals Private Limited is U47721DL2024PTC433477.

Where is Jinvik Pharmaceuticals Private Limited headquartered?

Jinvik Pharmaceuticals Private Limited is headquartered at D-565, Gali No-14, Kh No-517, Bhajanpura, East Delhi, Delhi, 110053.

When was Jinvik Pharmaceuticals Private Limited incorporated?

Jinvik Pharmaceuticals Private Limited was incorporated on 27 June 2024.

Who are the current directors of Jinvik Pharmaceuticals Private Limited?

The current directors of Jinvik Pharmaceuticals Private Limited are

Is Jinvik Pharmaceuticals Private Limited a listed company?

Jinvik Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Jinvik Pharmaceuticals Private Limited?

The authorized capital of Jinvik Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available